CLINICAL-SIGNIFICANCE OF NUCLEAR-DNA CONTENT IN PANCREATIC-CARCINOMA

被引:38
作者
ALANEN, KA
JOENSUU, H
KLEMI, PJ
NEVALAINEN, TJ
机构
[1] UNIV TURKU,CENT HOSP,DEPT PATHOL,SF-20520 TURKU 52,FINLAND
[2] UNIV TURKU,CENT HOSP,DEPT RADIOTHERAPY,SF-20520 TURKU 52,FINLAND
关键词
DNA index; Flow cylometry; pancreatic neoplasms; survival; S‐phase fraction;
D O I
10.1002/path.1711600407
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The nuclear DNA content or 62 pancreatic adenocarcinomas was analysed by flow cylometry from paraffinembedded material. Radical surgery could be performed in 12 of the 24 cases with diploid carcinoma, but only in 3 of the 38 cases with a non‐diploid tumour (P=0.0002); the radically resected carcinomas also had a lower fraction of cells in the S‐phase (P=0.009). Non‐diploid nuclear DNA content (38 cases, 61 per cent) was associated with advanced stage (P=0.002), poor histological differentiation (grade II or III, P=0.004), and primary tumour site in the body or the tail as compared with the head (P=0.01). The median survival time of the patients with diploid carcinoma was 13±3 (SE) months, and that of the patients with non‐diploid carcinoma 3±1 months (P=0.0001). The DNA index with the cutoff value 1.4 was a slightly more powerful prognostic factor than DNA ploidy, and it was the most important independent prognostic factor in Cox's multivariate analysis (P<0.001) followed by histological grade (P<0.03). We conclude that diploid pancreatic carcinomas are associated with a longer survival than the non‐diploid ones, and that radically operable carcinomas form a special subgroup with frequent diploidy and less aggressive biological behaviour. Copyright © 1990 John Wiley & Sons, Ltd.
引用
收藏
页码:313 / 320
页数:8
相关论文
共 29 条
[1]   AUTOLYSIS IS A POTENTIAL SOURCE OF FALSE ANEUPLOID PEAKS IN FLOW CYTOMETRIC DNA HISTOGRAMS [J].
ALANEN, KA ;
JOENSUU, H ;
KLEMI, PJ .
CYTOMETRY, 1989, 10 (04) :417-425
[2]   ANALYSIS OF PCP-DATA TO DETERMINE FRACTION OF CELLS IN VARIOUS PHASES OF CELL-CYCLE [J].
BAISCH, H ;
GOHDE, W ;
LINDEN, WA .
RADIATION AND ENVIRONMENTAL BIOPHYSICS, 1975, 12 (01) :31-39
[3]  
BARLOGIE B, 1983, CANCER RES, V43, P3982
[4]  
BRAGANZA JM, 1972, CLIN GASTROENTEROL, V1, P219
[5]  
DUNN E, 1987, SURG GYNECOL OBSTET, V164, P237
[6]  
GOULD VE, 1987, ARCH PATHOL LAB MED, V111, P791
[7]  
GUDJONSSON B, 1978, CANCER, V42, P2494, DOI 10.1002/1097-0142(197811)42:5<2494::AID-CNCR2820420554>3.0.CO
[8]  
2-R
[9]  
GUDJONSSON B, 1987, CANCER, V60, P2284, DOI 10.1002/1097-0142(19871101)60:9<2284::AID-CNCR2820600930>3.0.CO
[10]  
2-V